Literature DB >> 9469562

Blindness in glaucoma patients.

S Blomdahl1, B M Calissendorff, B Tengroth, O Wallin.   

Abstract

In order to determine the risk for bilateral blindness from glaucoma and to which extent other diseases are responsible for the disability, the registers of low vision clinics were surveyed. All registered patients still alive in 1991 with the diagnosis of glaucoma were included. Eighteen hundred and ninety-five patients fulfilled these criteria. Blindness was defined as bilateral visual acuity < or = 0.1. The majority of the patients (68%) had a visual acuity better than 0.1. The remaining 590 patients had a visual acuity < or = 0.1. In this latter group glaucoma was the reason for the low visual acuity in 20%, glaucoma in combination with other eye diseases in 35% and other eye diseases in 44%. Macular degeneration and cataracts were the main causes of the low vision in the latter group. The prevalence of glaucoma blindness in the Stockholm region was found to be 0.007% for glaucoma and 0.020% for glaucoma in combination with other eye diseases.

Entities:  

Mesh:

Year:  1997        PMID: 9469562     DOI: 10.1111/j.1600-0420.1997.tb00155.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  7 in total

1.  Appraising evaluations of screening/diagnostic tests: the importance of the study populations.

Authors:  R Harper; D Henson; B C Reeves
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

Review 2.  Novel drug delivery systems for glaucoma.

Authors:  E Lavik; M H Kuehn; Y H Kwon
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

3.  Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.

Authors:  Hussein O Ammar; H A Salama; M Ghorab; A A Mahmoud
Journal:  AAPS PharmSciTech       Date:  2009-06-18       Impact factor: 3.246

4.  The effect of different criteria on the number of patients blind from open-angle glaucoma.

Authors:  Anders Heijl; Johan Aspberg; Boel Bengtsson
Journal:  BMC Ophthalmol       Date:  2011-11-10       Impact factor: 2.209

5.  Low Vision Aids in Glaucoma.

Authors:  Anjani Khanna; Parul Ichhpujani
Journal:  J Curr Glaucoma Pract       Date:  2012-10-16

6.  Progression to severe visual impairment and blindness in POAG patients: pace and risk factors-a cohort study using German health claims data.

Authors:  Sophia Nestler; Daniel Kreft; Gabriele Doblhammer; Rudolf F Guthoff; Stefanie Frech
Journal:  BMJ Open Ophthalmol       Date:  2022-01-31

7.  Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics.

Authors:  Luca Rossetti; Maurizio Digiuni; Giovanni Montesano; Montesano Giovanni; Marco Centofanti; Antonio M Fea; Michele Iester; Paolo Frezzotti; Michele Figus; Antonio Ferreras; Francesco Oddone; Lucia Tanga; Teresa Rolle; Valentina Battaglino; Chiara Posarelli; Ilaria Motolese; Pietro Mittica; Simone Alex Bagaglia; Cristina Menicacci; Stefano De Cilla'; Alessandro Autelitano; Paolo Fogagnolo
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.